News

The oncolytic adenovirus was safe in terms of toxicity in mice models.

Heart patients discharged from the hospital with an opioid prescription were less likely to participate in planned follow-up care than those without prescribed opioids.

Largest observational study on antiepileptic treatment for poststroke epilepsy finds highest adherence to a less frequently prescribed drug.

Why any physician needs to have a strong sense of a patients' clinical history to distinguish endometriosis symptoms.

The burdensome disorder is highly prevalent in women. What treatment options are currently available?

A new study found that physician mothers commonly have responsibilities outside of their children and patients—and that such burdens are linked to more anxiety and burnout.

Exposure to excessive heat, especially during early pregnancy, is expected to drive an increase in congenital heart defects.

Inner-city African-American patients are 5 times more likely to have hypertensive emergency, according to a recent study.

According to updated statistics form the American Heart Association (AHA), cardiovascular disease is present in approximately 50% of US adults.

The number of babies born prematurely is steadily growing in the US. How can preeclampsia rates be lessened?

A new study found that deaths in the end-stage renal disease population correlated with seasonal trends in flu and flu-like illnesses.

The Mylan product has been approved as 3 different dosing strengths, inidicated for both asthma and COPD care.

A new cohort analysis shows patients switching or adding on the antipsychotic drug are not at a worse risk of suicide or other adverse events.

Eliot A. Brinton, MD, outlines the continued unmet needs for patients with familial chylomicronemia syndrome (FCS).

The ointment, which contains 3% CBD and 3% THC, will be tested for the treatment of psoriasis in an upcoming phase 2 trial.

The FDA has approved sumatriptan nasal spray (TOSYMRA, previously known as DFN-02) for the acute treatment of migraine with or without aura in adults.

Updates to the atrial fibrillation guidelines now recommend a newer type of blood-thinning medication called non-vitamin K oral anticoagulants (NOACs).

A new study finds patients who have high, real, or perceived risk of HIV are more likely to accept PrEP when they have access to it.

Parents hoping to spare their children from colds and the flu follow scientific recommendations in high numbers, but they are also susceptible to unscientific “folklore.”

The USPSTF continues to recommend universal prophylactic treatment with erythromycin ointment for all newborns.

UAB investigators sought to learn if neutrophil elastase exists in an exosomal form, and whether these exosomes could potentially bypass alpha1-antitrypsin inhibition to contribute to COPD.

The soon-to-be marketed therapy Dsuvia has shown enough benefit, tolerability, and safety to aid an at-need patient population in a controlled setting.

The medulloblastoma subset has a poor prognosis, so investigators have been looking for new treatment options.

Investigators found atypical responses from brain cells known as astrocytes, which follow traumatic brain injuries (TBIs), may be the cause of epilepsy development.

In the past 5 years, the administration has continually improved on the previous year's rate. More of the same should be anticipated in 2019.

The SPRINT MIND study did find that intensive treatment reduced the risk of mild cognitive impairment, a precursor to dementia.

Hilary Baldwin, MD, debunks the myths behind the nodular acne therapy she claims is a miracle drug.

The FDA has approved Janssen’s ibrutinib plus obinutuzumab for treatment-naïve patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).